Company
Stellaromics
Purpose-built for 3D Spatial Multi-omics in Thick Tissue Up To 100 µm.
Also known as Stellaromics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- Leading Research Institutions
- Legal name
- Stellaromics, Inc.
- stellaromics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Sample preparation, automated volumetric confocal imaging, data analysis, and visualization – all in one integrated platform designed for intact, thick tissue analysis.
Funding snapshot
- Total raised
- $25MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed2025-02-11
Funding rounds
- Round, 2025
- 2025-02-11
- Series A
- $25M2023-11-02, Company stated
Products
- Hardware
- Pyxa
Loading relationship preview